Vaxvec

Leishmania tarentolae vaccine vector
Vaxvec ID	29
Vaccine Vector Name	Leishmania tarentolae vaccine vector
Vector VO ID	VO_0001028
Safety	The lizard protozoan parasite Leishmania tarentolae is considered nonpathogenic to humans (Saljoughian et al., 2013). It has never been found associated with any form of human leishmaniasis.
Related Vaccine(s)	Recombinant vector vaccine A2-CPA-CPB(-CTE)-recombinant L. tarentolae (Leishmania infantum) L. T -HIV-1 Gag (Human Immunodeficiency Virus) L. T -PpSP15 (Leishmania major)
References	*Saljoughian et al., 2013:* Saljoughian N, Taheri T, Zahedifard F, Taslimi Y, Doustdari F, Bolhassani A, Doroud D, Azizi H, Heidari K, Vasei M, Namvar Asl N, Papadopoulou B, Rafati S. Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis. PLoS neglected tropical diseases. 2013; 7(4); e2174. [PubMed: 23638195].